Literature DB >> 22542722

[Orbital bone infarction in a child with homozygous sickle cell disease].

L Tostivint1, D Pop-Jora, E Grimprel, B Quinet, E Lesprit.   

Abstract

Vaso-occlusive crises are the most common complication of sickle cell disease. Orbital bone infarction is an unusual manifestation of sickling disorders. It is suspected in patients with acute painful periorbital swelling. Orbital compression syndrome with possible optic nerve injury is a rare but serious complication; therefore, this diagnosis should be considered. Orbital infarction can be difficult to distinguish from osteomyelitis or skin infections. Imaging can be helpful in differentiating infection from infarction. We report a case of orbital bone infarction in a 14-year-old boy with sickle cell disease. Under medical treatment, the clinical course resolved with no sequelae.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22542722     DOI: 10.1016/j.arcped.2012.03.016

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  3 in total

1.  Spontaneous bilateral intraorbital hematoma: A particular form of sickle cell disease complications in children.

Authors:  Haritanjona Andriamiarintsoa; Herveat Ramanandafy; Orlando Andoniaina Andriamiadanalisoa; Koloina Randriantianarisoa; Prosper Harinarivo Randrianarivelo; Emmylou Prisca Gabrielle Andrianah; Lova Hasina Ny Ony Narindra Rajaonarison; Léa Raobela; Joëlson Lovaniaina Rakotoson; Hanta Marie Danielle Vololontiana; Ahmad Ahmad
Journal:  Clin Case Rep       Date:  2022-06-24

2.  Bilateral orbital infarction and retinal detachment in a previously undiagnosed sickle cell hemoglobinopathy African child.

Authors:  Onakpoya Oluwatoyin Helen; K O Ajite; O A Oyelami; C M Asaleye; A O Adeoye
Journal:  Niger Med J       Date:  2013-05

3.  Sickle Cell Disease in Mauritania: epidemiological, clinical and therapeutic aspects about 135 cases.

Authors:  Mohamed Laghdaf Sidi; Amadou Mamadou N'Diaye; Mohamed Cheikh; Mohamed Mahmoud Heinhane
Journal:  Tunis Med       Date:  2022 avril
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.